Numerical simulation and parameter optimization of micromixer device using fuzzy logic technique.

The objective of this study is the design, simulation, and performance optimization of a micromixer device using the three input parameters of device structure, flow rate and diffusion coefficient of gold nanoparticles while the output parameters are concentration, velocity, pressure and time domain analysis. Each input parameter in the microfluidic chip influences the system output. The data were gathered through extensive study in order to optimize the diffusion control. The fuzzy logic approach is used to optimize the performance of the device with respect to the input parameters. In this study, we have chosen three different flow rates of 1, 5, and 10 µL min-1, three different diffusion coefficient values of low, average and high diffusivity gold nanofluids (15.3 e-12, 15.3 e-11, 15.3 e-10 m2 s-1) which are used in three different shapes of micromixer device, Y-shaped straight channel micromixer, herringbone-shaped micromixer, and herringbone shape with obstacles micromixer, and we measured the output performance, such as mixing efficiency, pressure drop, concentration across the microchannel and time domain. The data were obtained by fuzzy logic analysis and it was found that the herringbone shape with obstacles micromixer shows 100% mixing efficiency within a short duration of 5000 µm, and complete mixing was achieved within 10 seconds with a low pressure drop of 128 Pa.

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India.

Efficacy and safety data on quadrivalent influenza vaccines (QIVs) for immunization of Indian children are scarce. This phase 3, registration study evaluated the immunogenicity, safety, and tolerability of a QIV in Indian children aged 6-35 months (Group 1) and 3-17 y (Group 2). Subjects received one or two doses (0.5 mL each) of the study vaccine based on their priming status. Immunogenicity (post-vaccination geometric mean fold increase in hemagglutination inhibition [HI] titers and proportion of patients with seroprotection and seroconversion against the four influenza strains), unsolicited adverse events (AEs), and tolerability were analyzed. Among 118 subjects enrolled in each group, the geometric mean(standard deviation) fold increase in HI titers against A(H3N2), A(H1N1), B(Victoria), and B(Yamagata) strains were 31.7(5.33), 10.5(6.06), 4.1(5.70), and 8.6(5.34) in Group 1 and 14.0(4.37), 9.2(4.26), 14.3(6.73), and 14.4(5.41) in Group 2, respectively. Seroprotection was achieved by 91.2%, 83.3%, 41.2%, and 68.4% subjects in Group 1 and 100%, 95.8%, 73.7%, and 89.8% subjects in Group 2, respectively. Seroconversion was achieved by 87.7%, 66.7%, 41.2%, and 64.9% subjects in Group 1 and 89.0%, 78.8%, 69.5%, and 75.4% subjects in Group 2, respectively. Vaccination site pain and fever were the most common local and systemic reactions, respectively. Systemic reactions were more frequent in Group 1 (16.9% vs 7.6%). Most subjects (>90%) did not experience inconvenience within 7 d of vaccination; <10% in both groups reported unsolicited AEs. Thus, the QIV had a positive benefit/risk profile in Indian children/adolescents aged 6 months to 17 y.CTRI Registry No: CTRI/2018/05/014191Registry Name: Clinical Trials Registry - IndiaDate of Trial Registration: May 29, 2018Study Dates: August 03, 2018 (first subject first visit) to January 31, 2019 (last subject last visit)Drugs Controller General of India [DCGI] permission letter number: CT-03/2018.

Performance characteristics of virus neutralization test (VNT) and liquid phase blocking ELISA (LPBE) and their relationship in the cattle immunized with trivalent foot and mouth disease vaccine.

Virus neutralization test (VNT) and liquid phase blocking ELISA (LPBE) are accepted tests for screening and as in vitro alternativ to challenge in FMD vaccine potency testing. To replace VNT by LPBE for the screening of cattle, the optimized tests need to be first evaluated for their diagnostic performances. To replace it with LPBE in the absence of protection data, the interrelationship between VNT and LPBE have to be established to find out LPBE cut­off titer corresponding to the currently used VNT titers. Accordingly, VNT and LPBE were carried out using known negative (n = 306) and positive samples [Serotype O (n = 43), A (n = 14) and Asia1 (n = 11)], for the initial screening. The cut­off of < 1.5 log10 LPBE was comparable with that of < 1.2 log10 VNT titer for screening. LPBE was comparable to VNT in terms of specificity, sensitivity as shown by ROC curve and least varying (coefficient of variation 7.73% in LPBE vs 24.19% in VNT). Based on linear regression model using 471 bovine sera, the predicted LPBE titers corresponding to the currently used log 10 VNT titers of 1.65, 1.5 and 1.5, were 2.24, 1.87 and 2.00 for O, A and Asia1, respectively. These LPBE titers hence can be used as cut­off titers for classifying cattle as protected or not protected until correlation based on in vivo challenge between protection and antibody titer is established.

Enhanced shielding effectiveness in nanohybrids of graphene derivatives with Fe3O4 and ε-Fe3N in the X-band microwave region.

Novel nanocomposites of reduced graphene oxide (rGO)-Fe3O4, denoted as 'rGO:IO, and nitrogen doped rGO-ε-Fe3N, denoted as 'NrGO:IN', were prepared by a modified polyol method, wherein both the reduction of graphene oxide and oxidation of Fe2+/Fe3+ ions occurred simultaneously, followed by ammonia nitridation. The electron microscopy analysis of the rGO:IO and NrGO:IN nanocomposites revealed unique morphologies. In rGO:IO, the Fe3O4 nanoparticles having a mean diameter of 38 nm were found to be uniformly anchored to the rGO sheet surface, whereas in NrGO:IN, the ε-Fe3N nanoparticles (∼150 nm) were shielded by the NrGO sheets. Superparamagnetic and weak ferromagnetic characteristics with saturation magnetization values of 39.5 and 46 emu g-1 were observed in the rGO:IO and NrGO:IN nanocomposites respectively, which can be attributed to the nature of the constituent magnetic nanoparticles, Fe3O4 and ε-Fe3N. In addition, the graphene derivatives such as rGO and NrGO contributed to the enhanced electrical properties of the nanocomposite. The electrochemical impedance spectroscopy analysis showed that, compared to pure Fe3O4 and ε-Fe3N nanoparticles, the total electrical resistance of rGO:IO and NrGO:IN was reduced by 33 344.8 and 1569.87 Ω cm-2, respectively, when combined with the rGO and NrGO sheets. Further, the electromagnetic shielding performance of the NrGO:IN nanocomposite was investigated for the first time and was compared with the other samples. Of the two prepared nanocomposites, NrGO:IN exhibited electromagnetic shielding effectiveness of 35.33 dB at 11.4 GHz, which is considerably larger than that of rGO:IO (14.4 dB at 8 GHz). This enhanced shielding effectiveness is not only due to the high inherent magnetic and electrical properties of ε-Fe3N nanoparticles, but also due to the 'particle shielded by sheet' morphology of the NrGO:IN, which enhances the charge accumulation at the heterogeneous interfaces of NrGO sheets/ε-Fe3N nanoparticles.